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Leishmania actin was cloned, overexpressed in baculovirus-
insect cell system, and purified to homogeneity. The purified
protein polymerized optimally in the presence of Mg2 and
ATP, but differed from conventional actins in its following
properties: (i) it did not polymerize in the presence of Mg2
alone, (ii) it polymerized in a restricted range of pH7.0–8.5, (iii)
its critical concentration for polymerization was found to be
3–4-fold lower than of muscle actin, (iv) it predominantly
formed bundles rather than single filaments at pH 8.0, (v) it
displayed considerably higher ATPase activity during polymer-
ization, (vi) it did not inhibit DNase-I activity, and (vii) it did not
bind the F-actin-binding toxin phalloidin or the actin polymer-
ization disrupting agent Latrunculin B. Computational and
molecular modeling studies revealed that the observed uncon-
ventional behavior ofLeishmania actin is related to the diverged
amino acid stretches in its sequence, whichmay lead to changes
in the overall charge distribution on its solvent-exposed surface,
ATP binding cleft, Mg2 binding sites, and the hydrophobic
loop that is involved in monomer-monomer interactions. Phy-
logenetically, it is related to ciliate actins, but to the best of our
knowledge, no other actin with such unconventional properties
has been reported to date. It is therefore suggested that actin in
Leishmaniamay serve as a novel target for design of new antil-
eishmanial drugs.
Trypanosomatid parasites of the genus Leishmania are the
causative agents of several diseases ranging from relativelymild
cutaneous lesions to disfiguring mucocutaneous manifesta-
tions and fatal visceral leishmaniasis, affecting millions of peo-
ple worldwide (1). These organisms have a digenic lifecycle and
exist in two morphologically distinct forms, viz. promastigotes
and amastigotes. Whereas flagellated promastigote forms nor-
mally reside and divide in the alimentary tract of the sand fly
vector, aflagellated amastigote forms primarily exist within the
phagolysosomal complex of the mammalian macrophages (2).
The most characteristic structural feature of Leishmania para-
sites is their flagellar pocket, which is bound by the membrane
network devoid of microtubules, and is the only site that is
engaged in endocytotic and exocytotic processes (3, 4). These
processes in the trypanosomatids are essentially required not
only for nutrient uptake but also in evasion of host defense (5).
It has recently been shown that depletion of the cytoskeleton
protein, actin, in the bloodstream form of Trypanosoma brucei
inhibited endocytosis that subsequently resulted in cell death,
suggesting that actin is indispensable during this process (6).
Actin is a ubiquitous cytoskeleton protein in eukaryotes,
which exists in monomeric (G-actin) and filamentous (F-actin)
forms and plays an important role in several vital cellular pro-
cesses such as cell motility, cell division, endocytosis, intracel-
lular trafficking, etc. (7). Although this protein is well charac-
terized in a number of organisms including protozoans, like
Entamoeba (8),Tetrahymena (9, 10), Paramecium (11),Dictyo-
stelium (12),Plasmodium (13, 14), andToxoplasma (15), little is
known about the biochemical properties and cellular functions
of actin present in trypanosomatid parasites, such as Leishma-
nia and Trypanosoma (6, 16). However, it has recently been
shownby immunolabeling techniques that actin inLeishmania,
besides being present in cortical regions and the flagellar
pocket, is also present in the kinetoplast and nucleus, where it
appeared to co-localizewithDNA (16, 17).We therefore, envis-
age that actin in Leishmaniamay also be involved in other cel-
lular processes such as chromatin/k-DNA remodeling (18).
Earlier attempts to isolate Leishmania/Trypanosoma actin
by using a conventionalmethod ofDNase-I affinity chromatog-
raphy were unsuccessful, as this enzyme did not bind to
trypanosomatid actin in whole cell lysates (19). Also, staining
with fluorescently labeled phalloidin failed to stain filamentous
actin in these organisms (16, 19, 20).Moreover, no filament-like
structures corresponding to mammalian actin filaments (5–7
nm diameter) could be visualized by using electronmicroscopy
(20, 21). Based on these observations, it was believed that actin
may play only a limited role in cellular activities of trypanoso-
matid parasites, and that this protein is perhaps not a major
cytoskeleton protein in these organisms (20–22). However,
recent work from our laboratory has shown that Leishmania
contains abundant quantities of actin, which is mainly present
in the form of granules, patches, and filament-like structures
(16). It has further been shown that these filament-like struc-
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tures are associated with an F-actin-binding protein, coronin
(23).
To fully characterize the biochemical properties of Leishma-
nia actin (LdACT),3 we have now overexpressed this protein in
the baculovirus-insect cell expression system, purified it to
homogeneity, and compared its biochemical properties with
the purified rabbit muscle actin (RbACT). Comparative bio-
chemical analysis of the purified protein revealed that LdACT
markedly differed from RbACT in its various properties that
distinguish LdACT as a novel form of eukaryotic actin.
EXPERIMENTAL PROCEDURES
Cell Culture
Sf9 insect cells (Invitrogen) were maintained at 27 °C as
monolayer cultures in TNM-FH medium (Invitrogen). These
cells were routinely subcultured at 3–4-day intervals and were
replacedwith frozen stocks after every 3months. The Leishma-
nia donovani strain (DD8) was obtained from the National
Institute of Immunology, NewDelhi (India), andmaintained in
high glucose Dulbecco’s modified Eagle’s nutrient medium,
supplemented with 10% fetal bovine serum and 40 mg/liter
gentamycin at 25 °C. pENTR/SD/D-TOPO as a baculovirus
entry vector was procured from Invitrogen, whereas p6.5 as an
episomal expression vector was a kind gift from Prof. K. P.
Chang (University of Chicago, Chicago, IL).
Antibodies
Monospecific, polyclonal antibodies to Leishmania actin
(LdACT) and coronin (LdCORO) were raised in rabbits and
mice, respectively, and purified using published procedures (16,
23). Purified anti-recombinant LdACTand anti-LdCOROanti-
bodies specifically recognized only LdACT and LdCORO,
respectively, in the whole cell lysates of Leishmania promastig-
otes. Antibodies against ,-tubulins (monoclonals) were pro-
cured from ICN, antibodies against GRP78 was a kind gift from
Dr. E. Handman, and fluorophore-tagged IgGs were purchased
fromMolecular Probes.
Plasmid Construction, Transfection, and Expression
Expression of LdACT in the Baculovirus-Insect Cell System—
Genomic DNA from cultured L. donovani promastigotes was
isolated using standard protocol (24). For insect cell trans-
fection, the coding sequence of LdACT was PCR amplified
using primers 5-CACCATGGCTGACAACGAGCAGAG-
CTCCATCG-3 (forward) and 5-CTCGAGTTAGTGGTG-
GTGGTGGTGGTGGAAACACTTGTTATGCACGATGC-
TCGGCCC-3 (reverse), which incorporated sequence
coding for the His6 tag at the C terminus of the protein, and
genomic DNA as the template. The PCR product was subse-
quently cloned into viral transfer vector pENTR/SD/D-TOPO
and sequenced by the dideoxy chain termination method (25).
Entry vector containing LdACT was subjected to in vitro LR
recombination with linearized baculodirect genomic DNA at
25 °C (Invitrogen). Recombinant viruses were obtained after
96 h by transfection of LR recombination product into Sf9 cells
in the presence of 100M ganciclovir as per themanufacturer’s
instructions. Transfected Sf9 cells were assayed 96 h postinfec-
tion for the expression of LdACT-His6 (rLdACT) by 10% SDS-
PAGE andWestern blot analysis usingmousemonoclonal anti-
bodies against hexahistidine (AmershamBiosciences) as well as
rabbit monospecific polyclonal antibodies against LdACT, fol-
lowed by HRP-conjugated goat anti-mouse IgG/anti-rabbit
IgG. Signals were captured by chemiluminescence detection
(Millipore) and exposure to x-ray film.
Homologous Expression of LdACT in Leishmania Pro-
mastigotes—Episomal expression of LdACT in L. donovani pro-
mastigotes was made possible by a homologous episomal expres-
sion vector p6.5. The construct p6.5-LdACT was generated by
PCR amplification of LdACT using primers 5-GCTAGCATGG-
CTGACAACGAACAGAGCTCC-3 (forward) and 5-AAGCT-
TTCAGAAGCACTTGTTATGCACGATGCT-3 (reverse) and
genomicDNA as the template, and the PCR product was subse-
quently cloned in p6.5 vector at NheI andHindIII sites (present
in the vector multiple cloning site, and forward and reverse
primers respectively). The presence of LdACT in the construct
was examined by restriction enzyme digestion and the nucleo-
tide sequence was confirmed by DNA sequencing using the
dideoxy chain terminationmethod (25). 40g of both the p6.5-
LdACT construct and p6.5 control plasmids were transfected
separately into 107 L. donovani promastigotes by electropora-
tion (26). Transfected cells were further selected in the growth
medium containing tunicamycin up to 20 g/ml and main-
tained in the same conditions. Lysates of both p6.5-LdACT-and
p6.5-transfected promastigotes prepared by lysing equal num-
ber of cells were separated by 10% SDS-PAGE, transblotted
onto polyvinylidene fluoride membrane, washed, and blocked,
as described previously (16, 23), and probed with rabbit anti-
LdACT antibodies as well as mice anti-GRP78 antibodies (pro-
tein loading control) followed by HRP-conjugated goat anti-
mouse IgG and anti-rabbit IgG. Signals were captured by
chemiluminescence detection and exposure to x-ray film. Band
intensities were determined by densitometric analysis. The
level of LdACT expression in transfected promastigotes was
cross-confirmedby flow cytometry. For this, both p6.5-LdACT-
and p6.5-transfected promastigotes (106 cells) were harvested,
washed two times with phosphate-buffered saline, fixed with
4% paraformaldehyde, permeabilized with 0.1% Triton X-100
containing 0.5% glycine, and suspended in phosphate-buffered
saline. Cells were then treatedwith rabbit anti-LdACTantibod-
ies, followed by fluorescein isothiocyanate-conjugated anti-
rabbit IgG, and analyzed by using a FACS Calibur (BD Bio-
sciences) flow cytometer using Cell Quest support software for
acquisition and analysis.
Purification of Proteins
All the purification steps were performed in cold below
20 °C. Sf9 cells infected with recombinant baculovirus (multi-
plicity of infection 0.8) were harvested at 72 h postinfection and
lysed in 1 M Tris-HCl, pH 7.5, 0.6 M KCl, 0.5 mMNa2ATP, 1mM
dithiothreitol and protease inhibitors containing 0.5 mM 4-(2-
3 The abbreviations used are: LdACT, Leishmania actin; RbACT, rabbit actin;
TRITC, tetramethylrhodamine B isothiocyanate; HRP, horseradish peroxi-
dase; Cc, critical concentration; MOPS, 4-morpholinepropanesulfonic acid;
MES, 4-morpholineethanesulfonic acid; Ni2-NTA, nickel-nitrilotriacetic
acid.
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aminoethyl)benzenesulfonyl fluoride hydrochloride, 5mMben-
zamidine hydrochloride, 5 g/ml leupeptin, 1 g/ml E64, and
10 g/ml N-tosyl-L-lysine chloromethyl ketone hydrochlo-
ride. Cells lysate was clarified and dialyzed overnight into 15
mM MOPS, pH 7.0, 0.2 mM CaCl2, 0.2 mM dithiothreitol, 0.25
mM Na2ATP, and 1 g/ml leupeptin. Lysate was then passed
through a SP Sepharose column (Amersham Biosciences) two
times and flow through was dialyzed into G-buffer (5 mM Tris-
HCl, pH 8.2, 0.2 mM CaCl2, 0.2 mM dithiothreitol, and 0.25 mM
Na2ATP). After dialysis it was incubated with Ni2-NTA-aga-
rose beads for 1 h, preequilibrated with G-buffer. Beads were
washed with G-buffer containing 20 mM imidazole, and
rLdACT was eluted with G-buffer containing 200 mM imidaz-
ole. The eluted fraction was concentrated with an Amicon
Ultracentrifugal filter device (Millipore) and finally purified on
a Superdex 75 HR 10/300 column on AKTA fast performance
liquid chromatography (GEHealthcare). The peak fraction was
tested for purity by 12% SDS-PAGE and was found to be about
95% pure. Purified rLdACT thus obtained was utilized within
2–3 days for further experiments. Rabbit skeletal muscle actin
was purified from rabbit muscle acetone powder as described
by Pardee and Spudich (27) and stored in lyophilized form at
80 °C after addition of sucrose (2 mg/mg protein). RbACT
was subjected to size exclusion chromatography using a Super-
dex 75 HR 10/300 column on AKTA fast performance liquid
chromatography each time after thawing a new frozen vial, and
only the peak fractions of monomeric actin were used in the
experiments.
Actin Polymerization
Sedimentation Assay—Actin polymerization was monitored
by ultracentrifugation as reported earlier (28). Purified rLdACT
or RbACT was first incubated in G-buffer for 1 h on ice fol-
lowed by ultracentrifugation at 100,000 g for 20min at 4 °C to
remove traces of aggregates, if any. In the supernatant fractions,
actin polymerization was initiated by adding 1/10th volume of
10 F-actin buffer tomake the final concentration of 0.1 MKCl,
2mMMgCl2, and 2mMATP and incubated at 25 °C for another
2 h. Although the concentration of ATP used was higher, but
ATP in this range has been used earlier for the polymerization
of conventional as well as various homologs of actin, without
any adverse effect on actin (15, 29). Samples were centrifuged at
140,000 g at 25 °C for 2 h. Pellet fractions were washed once
with F-actin buffer, resolved on 10% SDS-PAGE, and stained
with Coomassie Brilliant Blue R-250 or transblotted onto poly-
vinylidene fluoride membrane and probed with rabbit anti-
LdACT antibodies followed by HRP-conjugated goat anti-rab-
bit IgG and chemiluminescence detection.
Fluorescence Quenching and Light Scattering Assay—Actin
polymerization was also monitored by measuring the decrease
in intrinsic tryptophan fluorescence as reported earlier (30).
Intrinsic tryptophan fluorescence emission spectra for actin
samples were obtained on a PerkinElmer LS50B Spectrolumi-
nescence meter in a 5-mm path length quartz cell. Samples
were excited with 290 nm and their respective emissions were
scanned from 300 to 500 nm. Actin polymerization was moni-
tored by adding 1/10th volume of 10 F-actin buffer to the
solution containing varying concentrations of protein followed
by incubation at 25 °C for 2 h. The critical concentration was
determined by plotting the change in fluorescence after adding
F-actin buffer to different concentrations of rLdACT or
RbACT. The time course of actin polymerization was moni-
tored by recording light scattering at 90° from the axis of inci-
dent light of 400 nm wavelength (excitation slit width 1.5 nm,
emission slit width 2.5 nm) as described previously (31) using
an RF-540 spectrofluorimeter.
DNase-I Inhibition and TRITC-Phalloidin Binding
DNase-I inhibition assay was performed in the presence of
rLdACT and RbACT as described earlier (32). Briefly, 10 l
of DNase-I (4M) was added to samples containing a range of
protein concentrations in G-buffer and incubated for 30min at
25 °C. Salmon spermDNA (6l of 10mg/ml)was added to each
sample prior to recording the absorbance at 260 nm in a Shi-
madzu UV-1650 PC Spectrophotometer. Linear rates of hyper-
chromicity were monitored for DNase-I activity and plotted in
terms of % inhibition of DNase-I activity with increasing con-
centrations of actin. Additionally, the effect of rLdACT and
RbACTon the activity of DNase-I was also compared by adding
both the actins separately to the reaction mixture containing
DNase-I and salmon sperm DNA followed by agarose gel elec-
trophoresis, as described earlier (33). For this, 100 ng of bovine
pancreatic DNase-I (Fermentas) was preincubated with 2
g/reaction of G-actin (rLdACT or RbACT) in DNase-I buffer
(10mMTris-HCl, pH 8.0, 4 mMMgCl2, 4 mMCaCl2) for 30min
at room temperature, followed by addition of 3 g/reaction of
salmon sperm DNA and the samples were incubated at room
temperature for another 45 min. To terminate the reaction, 25
mM EDTA was added to each reaction and the samples were
resolved on a 1% agarose gel and photographed under UV light.
Binding of phalloidin with F-actin on the other hand was ana-
lyzed using an earlier published procedure (28). Briefly,
rLdACTorRbACTover a range of protein concentrationswere
polymerized separately in F-actin buffer for 2 h at room tem-
perature. After polymerization, F-actin in each sample was
labeledwith 2MTRITC-phalloidin (sigma) and the increase in
fluorescence of TRITC-phalloidin was monitored by meas-
uring fluorescence (em585nm,ex 544 nm) on aPerkinElmer
LS50B Spectroluminescence meter. Additionally, binding of
the phalloidin to both rLdACT and RbACT was also analyzed
by measuring the decrease in tryptophan fluorescence of poly-
merized actin upon binding with phalloidin. For this, 2 M
rLdACT and RbACT with various replicates were polymerized
separately in F-actin buffer at 25 °C for 2 h. After polymeriza-
tion, increasing concentrations of the ligand (TRITC-phalloi-
din) were added and the samples were further incubated at
25 °C for 30 min. Finally, samples were analyzed for their
respective tryptophan fluorescence on a PerkinElmer LS50B
Spectroluminescence meter (em 300–500 nm, ex 290 nm).
ImmunofluorescenceMicroscopy
Leishmania promastigotes and infected Sf9 cells were fixed
with 4% (w/v) paraformaldehyde in 200 mM HEPES buffer (pH
7.2) at 25 °C for 30 min, and washed two times for 5 min each
with phosphate-buffered saline containing 0.5% (w/v) glycine.
The washed cells were allowed to adhere on the poly-L-lysine-
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coated coverslips. Fixed cells were permeabilized with 0.1%
(v/v) Triton X-100 and blocked with 10% (v/v) goat serum
(Amersham Biosciences) in phosphate-buffered saline for 30
min. After blocking, the cells were first incubated with primary
antibodies (10 g/ml) at 4 °C and then stained with Oregon
Green and/or Texas Red-X-tagged secondary antibodies (10
g/ml) at 4 °C for 4 h in the dark. Coverslips were mounted in
the mounting medium (Oncogene) and images were collected
using a 63, 1.4 NA (oil) Plan Apochromate lens on a Leica
DM5000B fluorescence microscope. Green and red images
were collected separately after excitation at 488 and 543 nm,
respectively, and merged for presentation.
ElectronMicroscopy
rLdACT and RbACTwere polymerized separately in F-actin
buffer at 25 °C for 2 h. For each specimen, 6 l of the samples
were allowed to adsorb for 2 min on a freshly glowed carbon-
coated copper grid (300 mesh). After blotting off the excess
fluid from the grid, staining was done with 1% aqueous uranyl
acetate solution. Finally, grids were air dried and observed
under a FEI Tecnai-12 Twin Transmission Electron Micro-
scope equippedwith a SISMegaView II CCD camera at 120 kV.
Measurements were done using AnalySIS software (SIS, Her-
zogenrath, Germany).
ATP Hydrolysis and Inorganic Phosphate Release Assay
ATP hydrolysis by RbACT and rLdACT during their polym-
erization was monitored by using the malachite green assay as
described earlier (34). Polymerization of both RbACT and
rLdACTwas initiated separately by the addition of10 F-actin
buffer at 25 °C. At 2-min intervals, the reaction was deprotein-
ized with 1 volume of cold 0.6 M perchloric acid and stored on
ice until all samples for the different time points were collected.
The samples were centrifuged and their supernatants were
removed for inorganic phosphate determination. To each sam-
ple 1/4th volume of coloring agent (0.44 g of malachite green,
3% (w/v) ammoniummolybdate, 0.2 ml of 11% Tween 20 in 2.6
N H2SO4) was added, incubated at room temperature for 30
min, and absorbance measured at 630 nm using a precision
microplate reader. The curves were normalized with KH2PO4
standard and a control without protein. Pi produced versus time
was plotted for various concentrations of both the actins. The
rate of Pi produced at the linear part of each curve was deter-
mined and plotted as a function of actin concentration to deter-
mine the rate of ATP hydrolysis presented in terms of Pi pro-
duced (M/min).
Release of inorganic phosphate during polymerization of
RbACT and rLdACT was determined with the EnzChek kit
(Molecular Probes) employing a procedure modified from the
manufacturer’s instructions because of significant absorbance
of light at 360 nmby polymerizedRbACTand rLdACT. Parallel
reactions were carried out with and without the EnzChek
enzyme and reactant components. Both reactions were read in
real time at 360 nm in a Shimadzu UV-1650 PC Spectropho-
tometer. Polymerization of both RbACT and rLdACTwere ini-
tiated by the addition of 10 F-actin buffer at 25 °C and the
absorbance of RbACTand rLdACTalonewere subtracted from
those of the complete reactions. A standard curve of Pi concen-
trations was employed as per the manufacturer’s instructions.
Phosphate release curves were overlain onto the 400-nm light
scattering curves of parallel polymerization reactions carried
out in the RF-540 spectrofluorimeter. The completion phase of
each curve was set to 100% and the values of each curve were
normalized with the 100% value.
Circular DichroismMeasurements
Ellipticity spectra were recorded between 200 and 250 nm in
a Jasco J810 spectropolarimeter calibrated with ammonium
()-10-camphorsulfonate. The values obtained were normal-
ized by subtracting the baseline recorded for the buffer having
the same concentration of the constituent ions under similar
conditions and the results were expressed as mean residual
ellipticity. Thermal denaturation was monitored by change in
molar ellipticity at 222 nm as a function of temperature on the
same spectropolarimeter, equipped with a peltier temperature
controller system. Sampleswere heated at constant rate of 1 °C/
min in a 1-mm path length cell.
Phylogenetic Analysis, HomologyModeling, andMolecular
Dynamics Simulations
The amino acid sequences of actin from various organisms,
viz. Amoeba proteus (gi 33946363), Dictyostelium discoideum
(gi 113218), Saccharomyces cerevisiae (gi 38372623), Parame-
cium caudataum (gi 15212111), Tetrahymena thermophila (gi
84344), Crypthecodinium cohnii (gi 19908693), Lingulodinium
polyedrum (gi 37694465),Toxoplasma gondii (gi 606857), Plas-
modium falciparum (ACT1, gi 160053), Cryptosporidium par-
vum (gi 113293), Cryptosporidium hominis (gi 54657132), Per-
kinsus marinus (gi 38112716), Arabidopsis thaliana (gi
30687201), Caenorhabditis elegans (gi 6626),Drosophila mela-
nogaster (gi 156773), Homo sapiens (-actin, gi 4501885), H.
sapiens (-actin, gi:28339), Trypanosoma brucei (gi 71755105),
and Leishmania donovani (gi:28627572) were aligned using
ClustalW software (35) and the alignment was saved in Phylip
format. Phylogenetic relationships of LdACT with actins from
various organisms were inferred from the PHYLIP package
(version 3.66) (36). Bootstraps were obtained with the SEQ-
BOOT program (1000 data sets were generated) and distance
matrices were generated with the PRODIST program (Jones-
Taylor-Thornton matrix). Neighbor-joining analysis was car-
ried out with the NEIGHBOR program using the input order of
sequences. Phylogenetic trees were drawn with TreeIllustrator
software (37). The three-dimensional model of the L. donovani
actin monomer was built based on four actin crystal structure
templates Orylactolagus cuniculus, Protein Data bank code
2A5X (38); C. elegans, PDB code 1D4X (39); S. cerevisiae, PDB
code 1YAG (39); and D. discoideum, PDB code 1NM1 (39)
using Modeler program interfaced with InsightII 2000.1 (40).
Subsequently, the model was energetically minimized with 500
steps of steepest descent minimization, followed by 2000 steps
of conjugate gradient minimization to remove the geometrical
strain. To further investigate the ATP binding with L. donovani
actin, the ATP was manually docked to the binding site based
on the previous structural information (41).
This initial binary complex structure was further refined by
energyminimization. To examine the ATP-induced conforma-
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tional changes in L. donovani actin, two independent 500-ps
MD simulations in the presence and absence of ATP were car-
ried out with the CHARMM program using CHARMM force
field (42). All L. donovani actin systems were solvated using
Explicit Spherical Boundary with harmonic restraints (sphere
of 50 Å radius). This solvated complex was subjected to energy
minimization first by 500 steps of steepest descent followed by
2000 steps of conjugate gradient method. The system was
heated from 50 to 300 K over a period of 50 ps with a time step
of 1 fs and the velocities being reassigned in the system every
0.05 ps. The system was further equilibrated with a 1-fs time
step, for 100 ps so that the energy of the system achieves com-
plete stability. Production runs were performed at 300 K and
carried out under a constant number of particles, volume, and
temperature conditions for 500 ps with a 1-fs time step. All the
bonds involving hydrogen atom
were constrained using the SHAKE
algorithm in all simulations (43).
The molecular trajectory for the
systems generated by the molecular
dynamics simulations were ana-
lyzed using the VMD (44) software
and the CHARMM program (42).
RESULTS
Cloning, Overexpression, and
Purification of rLdACT
Several attempts were made to
purify native LdACT, or recombi-
nant protein using the yeast expres-
sion system, but without any suc-
cess. However, we could successfully
purify this protein in its properly
folded form by expressing it in the
baculovirus-insect cell expression
system. A hexahistidine tag was
attached to the C terminus of LdACT
to facilitate the purification process,
because earlier studies have shown
that thepresenceof theHis6 tag at the
N or C terminus of actins has no sig-
nificanteffecton theirpolymerization
properties (15, 45, 46). LdACTwith a
C-terminalHis6 tagwas clonedunder
control of the polyhedron promoter
of baculovirus and the presence of
LdACT-His6 in the viral genome was
confirmed by PCR (data not shown).
LdACT-His6 was subsequently ex-
pressed in Sf9 insect cells as a recom-
binant protein (rLdACT) that accu-
mulated in the cytosol of host cells, as
shown by SDS-PAGE analysis of the
lysate aswell as by fluorescence imag-
ing of 72 h post-infected Sf9 cells (Fig.
1, A and B). rLdACT was purified
from infected Sf9 cells harvested at
72 h postinfection with subsequent
ionexchange,Ni2-NTA, andsize exclusionchromatographyand
onlymonomeric peak fractionswere used for further experiments
(Fig. 1, B–D). Structural integrity of the purified rLdACT was
established by comparing its tryptophan fluorescence (Fig. 1E)
spectra and far UV-CD (Fig. 1F) spectra with that of RbACT. To
ruleout thepossibility of partial unfoldingof rLdACTduringpuri-
fication, we measured the unfolding kinetics of rLdACT and
RbACT under identical conditions; both rLdACT and RbACT
unfolded approximately with the same rates (0.2514 and 0.2307
min1, respectively) when their thermal denaturation was moni-
tored in the same transition zone (50–65 °C) (Fig. 1G).
Properties of rLdACT
rLdACTDiffers fromRbACT in Its PolymerizationConditions—
Polymerization of both rLdACT and RbACT was monitored
FIGURE 1. Expression, purification, andbiophysical characterization of rLdACT.A, expression of rLdACT in
Sf9 cells after 72 h post-infection with recombinant baculovirus, (a) phase, and (b) fluorescence image of
infected Sf9 cells stained with rabbit anti-rLdACT antibodies followed by fluorescein isothiocyanate-conju-
gated anti-rabbit IgG. Bar, 5 m. B, Coomassie-stained SDS-polyacrylamide gel electrophoretic analysis of
recombinant L. donovani actin (rLdACT) overexpressed in Sf9 cells. Lane 1, molecular weight markers; lane 2,
uninfected Sf9 cells; lane 3, Sf9 cells after 72 h post-infectionwith recombinant baculovirus; lane 4, eluate after
Ni2-NTA chromatography containing purified rLdACT. C, size exclusion profile of the rLdACT after Ni2-NTA
chromatography showing the monomeric nature of purified rLdACT and only the peak fractions were used in
further experiments.Arrowsmark peak positions of themarker proteins: albumin (67 kDa), ovalbumin (43 kDa),
chymotrypsinogen (25kDa), ribonucleaseA (13.7 kDa). Inset shows theapparentmolecularmassof thepurified
rLdACT to be 43 kDa. D, molecular identity of rLdACT by Western blot analysis; a, Coomassie-stained gel: lane
I, molecular weight markers; lane II, purified rabbit muscle actin (RbACT); lane III, purified rLdACT. b, Western
blot developed using rabbit anti-rLdACT antibodies followed by HRP-conjugated anti-rabbit IgG, which
detected only rLdACT (lane III) in the blot and not RbACT (lane II). c, blot was stripped off and the sameblotwas
developed after probing it with mice anti-His6 monoclonal antibody followed by HRP-conjugated anti-mice
IgG,whichdetected rLdACT (lane III) aswell as themolecularmassmarker of 116 kDa (lane I) that also contained
aHis6 tag (positive control). E, fluorescence emission spectra of rLdACT (solid line) and RbACT (dotted line). F, far
UV CD spectra of rLdACT (filled circles) and RbACT (open circles). G, thermal unfolding of rLdACT (filled circles)
and RbACT (open circles) in terms of percentage ellipticity plotted versus temperature.
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under various conditions by both pelleting and light scattering
assay. Although maximum polymerization of both rLdACT
and RbACT was observed when ATP was used along with
Mg2, rLdACT unlike RbACT, underwent polymerization
even in the complete absence of any divalent cation (Fig. 2, A
and B). Moreover, very little, if any,
polymerization of rLdACTwas seen
when Mg2 alone or Mg2 with
GTP were used in the polymeriza-
tion medium, whereas considerable
polymerization of RbACT was
observed under these conditions,
suggesting higher preference of
rLdACT for ATP as a nucleotide
and that Mg2 alone in the polym-
erization buffer is not sufficient
enough to induce polymerization of
rLdACT. These observations fur-
ther gain strength when the time
course of polymerization of both
rLdACT and RbACT was moni-
tored in the presence ofMg2 alone
and in combination with ATP (Fig.
2,C andD). A significant increase in
light scattering intensity was
observed when polymerization of
RbACT was monitored in the pres-
ence of Mg2 alone, whereas no
light scattering intensity enhance-
ment was observed under similar
conditions with rLdACT. To rule
out the possibility of denaturation
of rLdACT in the absence of ATP,
polymerization up to the first 500 s
was monitored in the presence of
only Mg2, which revealed no
increase in light scattering intensity
suggesting insignificant polymeri-
zation, however, after the first 500 s,
when ATPwas supplemented in the
same reaction mixture, a significant
increase in light scattering intensity
was observed that followed the
same time course of polymerization
as in the presence of ATP andMg2
(Fig. 2C), thus suggesting ATP as an
essential component for the polymer-
ization of rLdACT. The possibility of
structural alterations in rLdACT in
the presence of Mg2 alone was fur-
ther eliminatedbymeasuring its tryp-
tophan fluorescence and far UV CD
spectra in the presence of the Mg2
(supplemental Fig. S1). It may be
noted that amajor part of both actins
was found to be in supernatant frac-
tions. To rule out the possibility of
some amount of denatured protein in
these fractions, we analyzed the structural integrity of the super-
natant protein that was found to be unchanged (data not
shown). Itmay therefore be envisaged that the actins remaining
in the supernatant may exist in the form of short filaments that
could not be sedimented at the measured speed of centrifuga-
FIGURE2.Polymerizationpropertiesof rLdACTandRbACTassessedbypelletingand90° light scattering
assay. A, Coomassie-stained SDS-polyacrylamide gel of rLdACT and RbACT under different ionic or nucleotide
conditions after centrifugation at 140,000 g. P, actin in pellet fraction, and S, actin in supernatant fraction.
Both the actinswere used at the concentration of 5M. B, bar graph representing percentage of actins in pellet
fractions. Dark gray bars, rLdACT; light gray bars, RbACT, values shown are mean of three independent experi-
ments S.D. C, light scatteringmeasurements of 5M rLdACT in the presence of (i) 2mMMg2 and 2mMATP,
(ii) 2 mM Mg2 followed by 2 mM ATP supplementation after 500 s (marked by arrow), and (iii) 2 mM Mg2. D,
light scattering measurements of 5 M RbACT in the presence of (i) 2 mMMg2 and 2mM ATP, (ii) 2 mMMg2.
FIGURE 3. pH-dependent polymerization of rLdACT. A and B, Coomassie-stained SDS-polyacrylamide gel
electrophoretic analysis of LdACT and RbACT, after their polymerization at different pH values and centrifuga-
tion at 140,000 g. P, actin in pellet fraction, and S, actin in supernatant fraction. Both actins were used at a
concentration of 5 M. C and D, bar graph representing the percentage of actins in pellet fractions of rLdACT
and RbACT. Dark gray bars, rLdACT; light gray bars, RbACT, values shown are mean of three independent
experiments  S.D. Buffers at pH (i) 6.0 (MES), (ii) 7.0 (HEPES), (iii) 8.0 (Tris), and (iv) 9.0 (Tris) were used for
polymerization.
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tion. This apart, polymerization of rLdACT occurred in a nar-
row range of pH from 7.0 to 8.5 and no polymerization was
observed when pH of the medium was7.0, however, RbACT
was observed to polymerize in a broad pH rangewithmaximum
polymerization at pH 6.0 (Fig. 3).
Critical Concentration (Cc) for Polymerization of rLdACT Is
Significantly Lower Than of Conventional Actin—Polymeriza-
tion of rLdACT and RbACT at varying concentrations was
monitored by measuring the quenching of their intrinsic tryp-
tophan fluorescence after addition of F-actin buffer (Fig. 4A).
This was based on the earlier studies that showed that intrinsic
tryptophan fluorescence is quenched when G-actin is con-
verted into F-actin under in vitro
conditions (30). Upon plotting the
change in tryptophan fluorescence
as a function of monomeric actin
concentration, the Cc of rLdACT
and RbACTwere calculated around
0.04 and 0.16 M, respectively (Fig.
4B). This was further validated by
monitoring actin polymerization by
the sedimentation assay, which
showed a linear increase in amounts
of actin in the pellet fractions with
increasing rLdACT concentrations
above 0.04 M (data not shown).
Based on the earlier observations
that cytochalasin D inhibits polym-
erization at the barbed ends and
thereby polymerization occurs only
at the pointed ends (47), we deter-
mined the Cc of rLdACT and
RbACT in the presence of 5 M
cytochalasin D. Cc of both RbACT
and rLdACT increased to 2.9 and
0.08 M, respectively (Fig. 4C).
Latrunculin B has earlier been
shown to interact with actin in 1:1
stoichiometry and affect its Cc (48).
We, therefore, determined the Cc of
rLdACT and RbACT in the pres-
ence of 5 M Latrunculin B.
Whereas the Cc of RbACT was
altered to 2.4 M, the Cc of rLdACT
remained unaffected (Fig. 4D), sug-
gesting that Latrunculin B does not
affect the polymerization of
rLdACT under in vitro conditions.
rLdACT Predominantly Assem-
bles in the Form of Bundles at pH 8.0
—rLdACT and RbACT were poly-
merized in vitro at various concen-
trations under identical conditions,
and the polymers thus formed were
analyzed by electron microscopy.
Unlike RbACT (Fig. 5A, panel a),
rLdACT at the concentration of 2
M existed largely in the form of
bundles (Fig. 5A, panel b), however, when the concentration of
rLdACT in the polymerization mixture was lowered to 0.2 M
and the pH of the F-actin buffer was brought down from 8.0 to
7.0, besides forming bundles, it also existed in the form of fila-
ments (Fig. 5A, panel c). The average diameter of these in vitro
assembled rLdACT filaments was found to be around 5 nm,
which was well within the range of the diameter of in vitro
assembled filaments of other eukaryotic actins (5–7 nm).
Homologous Expression of LdACT in Leishmania Reveals
Long Cables of Actin—Earlier studies from our laboratory have
shown that actin is abundantly present in Leishmania, which
mainly exists in the form of granules, patches, and filament-like
FIGURE 4. Critical concentration determination of rLdACT. A, tryptophan fluorescence quenching curves of
rLdACT at its different concentrations (M) in G-buffer (a) and F-buffer (b). Measurements were made 2 h after
addition of F-buffer. B, (a) plot of change in tryptophan peak fluorescence between G-buffer and F-buffer as a
functionof therLdACTconcentrationrevealedtheCcof rLdACTtobe0.04M, (b)plotofchange in thetryptophan
peak fluorescence between G-buffer and F-buffer as a function of RbACT concentration, which revealed the Cc of
RbACT tobe0.16M.C, (a) Ccof rLdACT in thepresenceof 5McytochalasinD, (b) CcofRbACT inpresenceof5M
cytochalasinD.D, (a) Ccof rLdACT inpresenceof5MLatrunculinB, (b) CcofRbACT inpresenceof5MLatrunculinB.
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structures (16). It was further shown that the filament-like
structures of actin are invariably associated with an actin-bind-
ing protein, coronin (23). To analyzewhether overexpression of
actin in Leishmania cells would increase the occurrence of its
filamentous form in these cells, we episomally overexpressed
LdACT in L. donovani promastigotes and then analyzed the
status of actin. The levels of actin expression in Leishmania
cells that were transfected with the p6.5-LdACT construct
(transgenic cells) were compared with the cells that were trans-
fected with the vector alone (control cells) by Western blot
analysis, using GRP78 as the internal protein control (supple-
mental Fig. S2B) as well as by flow cytometry (supplemental Fig.
S2C). The levels of actin in the transgenic cells were 3–4 times
greater than that in the control parasites. To examine the status
of actin in these cells, we immunostained both the transgenic
and control cells with anti-LdACT, anti-LdCORO, and anti-
,-tubulin antibodies and then analyzed the stained cells with
immunofluorescence microscopy (Fig. 5B). LdACT in trans-
genic parasites was predominantly present in the form of long
filaments that largely existed as cables, whereas in control cells
it was present as granules, patches, and short filaments. Inter-
estingly, most of the actin filaments and cables seen in the
transgenic cells, like the control cells were found to be deco-
ratedwith endogenous coronin, fur-
ther confirming the ability of coro-
nin to invariably associate with
filamentous actin in Leishmania
cells.
rLdACT Exhibits Higher ATPase
Activity and Fast Pi Release during
Its Polymerization—Hydrolysis of
tightly bound ATP in actin fila-
ments (F-ATP actin 7 F-ADPPi
actin) followed by the release of Pi to
form F-ADP actin is a characteristic
property of all eukaryotic actins
during their polymerization. The
intermediate F-ADPPi actin thus
formed assures stability of the fila-
ments, whereas Pi release from the
complex has been shown to be an
elementary step responsible for the
weakening of the monomer-mono-
mer interactions within the fila-
ments (49, 50). Because amino acid
sequence alignment of five ATP-
binding motifs (two adenosine ring
binding and three phosphate bind-
ing) in LdACT with ATP-binding
motifs of other eukaryotic actins
(51) revealed a high degree of diver-
gence in motif 3 of LdACT that
binds the adenosine ring, we deter-
mined the effect of this difference
on ATP hydrolysis. Pi release as well
as ATP hydrolysis during polymeri-
zation of both rLdACT and RbACT
were monitored following the
standard procedure (31). rLdACTwas found to assemblewith a
much higher rate of Pi release as a consequence of higher ATP
hydrolysis as compared with RbACT (Fig. 6).
rLdACT Does Not Inhibit DNase-I Activity—All eukaryotic
actins are known to bind DNase-I and inhibit its activity with
the exception of Entamoeba and Tetrahymena actins (8, 9).
Because the DNase-I binding loop in LdACT is highly diverged
as compared with mammalian actins (16), we compared the
effects of rLdACT and RbACT on the activity of DNase-I.
Although RbACT inhibited DNase-I activity up to 97% even at
low concentrations, rLdACT did not affect DNase-I activity at
all (Fig. 7A) under identical conditions. This was further con-
firmed by agarose gel electrophoresis of salmon sperm DNA
digestedwithDNase-I in the presence or absence of rLdACTor
RbACT. Fig. 7B shows that DNase-I incubated with rLdACT
completely hydrolyzed salmon sperm DNA (lane 4), similar to
control DNase-I without any actin (lane 2). However, DNase-I
did not hydrolyze salmon sperm DNA when rLdACT was
replaced with RbACT in the incubation mixture (lane 5), dem-
onstrating the inability of rLdACT to inhibit DNase-I activity.
The possibility of intrinsic endonucleolytic activity in the puri-
fied protein was eliminated by incubating salmon sperm DNA
with rLdACT and RbACT separately (Fig. 7B, lanes 6 and 7).
FIGURE 5. In vitro and in vivo analysis of LdACT filaments. A, a, electron microscopic images of in vitro
constituted RbACT filaments in F-buffer (pH 8.0) at 2Mprotein concentration. b, electronmicroscopic images
of in vitropolymerized rLdACT filaments under identical buffer conditions, pH8.0, andprotein concentration (2
M) as in RbACT, which revealed the existence of rLdACT filaments primarily in the form of bundles. c, to
visualize isolated filaments rLdACT was polymerized at a concentration of 0.2 M and the pH of F-buffer was
lowered to 7.0. Under these conditions, RbACT does not form well defined filaments. B, immunofluorescence
imaging of control and transgenic promastigotes. (i) control promastigotes: (a) phase, (b) labeled with anti-
LdACT antibodies (red), (c) labeled with anti-LdCORO antibodies (green), and (d) merge of b and c. Arrowhead
shows colocalization of actin filaments with coronin in the control promastigotes. (ii) transgenic promastig-
otes: (a) phase, (b) labeled with anti-LdACT antibodies (red), (c) labeled with anti-LdCORO antibodies (green),
and (d) merge of b and c. Arrowhead shows colocalization of almost the entire endogenous F-actin-binding
protein, coronin, with bundles of LdACT filaments. (iii) transgenic promastigotes: (a) phase, (b) labeled with
anti-LdACT antibodies (red), (c) labeled with anti-tubulin antibodies (green), and (d) merge of b and c. Arrow-
head shows bundles of actin filaments in the transgenic promastigotes. Bar, 5 m.
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TRITC-Phalloidin Does Not Bind rLdACT Filaments—
TRITC-phalloidin, a fluorescently labeled bicyclic peptide,
binds and stabilizes actin filaments in vitro and microfilaments
inside the cell (7). Although we have already reported the
inability of fluorescently labeled phalloidin to stain filament-
like structures of actin in Leishmania (16), it was not clear
whether Leishmania actin failed to bind phalloidin due to some
conformational alterations in its structure or the observed
inability was merely due to the in situ masking of phalloidin-
binding sites by some actin-binding proteins. To address this,
we compared the binding of TRITC-phalloidin with in vitro
polymerized rLdACT and RbACT by measuring the enhance-
ment in fluorescence ofTRITC-phalloidin at 585 nmafter incu-
bating it with varying concentrations of polymerized actins. Fig.
7C shows that unlike RbACT, rLdACT did not show any
enhancement of fluorescence even at 4 M rLdACT concen-
tration, suggesting that rLdACT filaments have no affinity
for TRITC-phalloidin at the measured concentrations. To
rule out the possibility of failure of fluorescence enhance-
ment of TRITC-phalloidin upon binding with rLdACT fila-
ments due to the intrinsic nature of rLdACT, we measured
the tryptophan fluorescence of polymerized rLdACT and
RbACT after addition of increasing concentrations of phalloidin.
As amatter of fact, binding of phalloi-
din to actin filaments should decrease
its tryptophan fluorescence intensity
at 340 nm, which was observed
with RbACT, however, polymerized
rLdACT did not show any significant
decrease in its fluorescence intensity
at 340 nm even at higher concentra-
tions of phalloidin (Fig. 7, D and E),
thus showing the inability of rLdACT
filaments to bind TRITC-phalloidin.
Similar lack of phalloidin binding has
earlier been reportedonlywithTetra-
hymena actin (9).
Phylogenetic Analysis
Although, the primary amino
acid sequence of LdACT is 70%
identical to other eukaryotic/con-
ventional actins, key residue dif-
ferences could bring diversity in
the overall structure that might be
responsible for its unconventional
behavior. LdACT showed high
divergence in a few amino acid
residues, viz. 1–9, 40–53, 194–
200, 229–240, 266–281, and 307–
315, that have been found to be
conserved in mammalian actins.
These differences in LdACT were
phylogenetically analyzed with
respect to the sequences of other
available eukaryotic actins. A den-
drogram based on neighbor-join-
ing analysis was generated by com-
paring various available actin sequences from different
organisms including LdACT using the PHYLIP program and
robust tree topologies thus obtained were found to be in
agreement with previously known taxonomic classifications.
Fig. 8 shows the neighbor-joining analysis tree obtained with
1000 bootstrap replicates. The resulting phylogenetic tree
exhibited a major cluster involving trypanosomatid actins
and ciliate actins. These results clearly suggest that despite a
high level of identity to eukaryotic/conventional actins, key
differences are conserved among LdACT and ciliate actins.
HomologyModeling andMolecular Dynamics Simulation
Highly unconventional biochemical properties of LdACT
observed here strongly suggest that LdACT may signifi-
cantly differ from other eukaryotic actins in its three-dimen-
sional structure. To evaluate this possibility, we developed
an in silico energetically minimized model of LdACT using
computational modeling along with molecular dynamic sim-
ulations. A three-dimensional model of L. donovani actin
monomer, based on four crystal structure templates of actin
(O. cuniculus, PDB code 2A5X; C. elegans, PDB code 1D4X;
S. cerevisiae, PDB code 1YAG; D. discoideum, PDB code
1NM1) was generated and subsequently subjected to energy
FIGURE6.ATPhydrolysis andPi releaseduring thecourseofpolymerizationof rLdACTandRbACT.A, plot
showing comparison of the rate of ATP hydrolysis during in vitro polymerization of varying concentrations of
rLdACT (filled circles) and RbACT (filled squares) under identical conditions. Measurements weremade up to 30
min after addition of F-buffer using themalachite green assay as described under “Experimental Procedures.”
Pi produced versus time were plotted for various concentrations of both the actins. The rate of Pi produced at
the linear part of each curvewas determined and plotted as a function of actin concentration to determine the
rate of ATP hydrolysis presented in terms of Pi produced (M/min). Values shown aremean of three independ-
ent experiments  S.D. for each concentration of both the actins. B and C, time-dependent Pi release (black
lines) during polymerization of 5 M rLdACT, compared with 5 M RbACT, respectively. Measurements were
done using EnzChek kit as described under “Experimental Procedures” and the kinetics of Pi release of rLdACT
and RbACT were overlaid with their respective polymerization curve (gray lines) measured separately under
identical conditions in a RF-540 spectrofluorimeter. The completion phase of each curve was set to 100% and
the values of each curve were normalized with the 100% value.
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minimization and molecular dynamics simulation in the
presence or absence of ATP as described under “Experimen-
tal Procedures.” All the key diverged amino acid residues
were found to be concentrated on the surface of the mono-
mer, especially including those regions that participate in
filament formation, like DNase-I loop (Fig. 9A). However,
interestingly this loop showed similar high fluctuations
throughout the simulation (Fig. 9B), as found in the simula-
tions with other conventional actins (52), suggesting the
retention of overall flexibility in the DNase-I loop even after
high diversity. Moreover, apart from the DNase-I loop a
region in subdomain 4 also
showed marked fluctuations as
revealed by average root mean
square fluctuations values, indi-
cating the retention of flexible
regions involved in filament for-
mation. However, diverse residues
could alter interactions within the
filaments or between the filaments
or both, which could be better
explained after exploring the
structures of LdACT filaments. As
revealed by the atomic structure of
the actinDNase-I complex (41),
the major contacts between actin
and DNase-I involved residues
Gly42, Val43, and Met44 of actin,
which are replaced by Met, Gln,
and Ala, respectively, in LdACT,
thereby making LdACT unable to
inhibit DNase-I activity. More-
over, in the same atomic structure
Thr203, Glu207, and Lys61 have
been shown to form weak electro-
static interactions with DNase-I,
which were conserved in LdACT
(Fig. 9A), suggesting the prime
importance of the major interac-
tions in DNase-I inhibition by
actin. Divergence in the key resi-
dues also brought about a high
variation in the solvent-exposed
surface charges in LdACT (Fig.
10A). Additionally, subdomain 2
was observed to be more closer to
subdomain 4 (10.447 Å) compared
with rabbit actin (13.872 Å), which
led to structural alterations in the
ATP-binding cleft resulting in the
smaller cleft volume as compared
with rabbit actin (Fig. 10A).
ATP binding cleft in LdACT is
formed by residues Gly14, Ser15,
Gly16, Met17, Lys19, Gln138, Asp155,
Asp158, Lys214, Glu215, Gly303,
Ser304, Met306, Phe307, and Lys337
and lies between the lobes formed
by subdomains 1 and 2 and subdomains 3 and 4 (Fig. 10B).
These residues were consistent with the earlier reported resi-
dues for ATP binding with rabbit actin (41). To further under-
stand how theATP binding site reorganized itself upon binding
of ATP, we compared the side chain orientations of the LdACT
and the binary complex (with ATP). Among the residues that
interacted with ATP, Lys19 showed the most dramatic confor-
mational change. In the initial “apo” structure, Lys19 pointed
away from theATPbinding site, but in ourmolecular dynamics
simulations of the apoprotein, Lys19 showed considerable flex-
ibility and changed orientation often. In the binary complex
FIGURE 7.DNase-I inhibition activity and TRITC-phalloidin binding of rLdACT and RbACT.DNase-I inhibi-
tion assay: A, plot showing percentage of pancreatic DNase-I (100 nM) inhibition by increasing concentrations
ofmonomeric RbACT (filled squares) and rLdACT (open circles) in the solution; B, agarose gel electrophoresis of
salmon sperm DNA digested with pancreatic DNase-I in the presence or absence of monomeric rLdACT or
RbACT. Lane 1, 1-kbDNA ladder; lane 2, 100 ngofDNase-I 3gof salmon spermDNA (ve control); lane 3, 3g
of salmon spermDNA (ve control); lane 4, 100ngofDNase-I2gof rLdACT3gof salmon spermDNA; lane
5, 100ngofDNase-I2gRbACT3gof salmonspermDNA; lane 6, 2gof rLdACT3gof salmonsperm
DNA; lane 7, 2 g of RbACT  3 g of salmon sperm DNA. C, plot showing fluorescence intensity of 2 M
TRITC-phalloidin after incubating with increasing concentrations of polymerized rLdACT (open circles) and
RbACT (filled squares), values shown are mean of three independent experiments S.D. D, tryptophan fluo-
rescence spectra of polymerized RbACT and rLdACT (inset) at 2Mprotein concentration after incubatingwith
increasing concentrations of TRITC-phalloidin. E, plot showing a comparison of the percent decrease in tryp-
tophan fluorescence intensity of polymerized RbACT (solid squares) and rLdACT (solid circles) with increasing
concentrations of TRITC-phalloidin, which shows no affinity of polymerized rLdACT with TRITC-phalloidin.
Values shown are mean of three independent experiments S.D.
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simulation, the hydrogen bond between Lys19 and ATP formed
andwas very stable throughout the trajectory. However, in rab-
bit actin, the corresponding Lys18 residue did not show any
direct interactions with ATP (41). Another conserved residue
that underwent a major conformational change upon ATP
binding was Ser15. In molecular dynamics simulations of the
apoprotein, this residue never changed orientation to point to
the ATP binding site. However, in the binary complex, Ser15
was found to move toward the ATP-binding site before simu-
lation started and stayed in this orientation throughout the sim-
ulations. Additionally, the backbone nitrogen atom of Gly303
formed ahydrogen bondwith theO-1 atomof the-phosphate.
Similarly, the - and -phosphates of ATP formed hydrogen
bonds with main chain nitrogen atom of Ser15, Met17, and
Asp158. The -and -phosphates of ATP also interacted with
LdACT by forming hydrogen bonds with the side chain nitro-
gen atom of Lys19 and Lys214 of LdACT interacted by forming
hydrogen bonds with the oxygen atoms of the sugar moiety of
ATP.
DISCUSSION
rLdACT, similar to conventional actins, undergoes optimal
polymerization in the presence of Mg2 and ATP. However,
unlike muscle actin, it failed to polymerize when Mg2 alone
was used in the polymerization
medium, suggesting that its binding
withMg2 alone is perhaps not suf-
ficient enough to induce its polym-
erization. Previously, it has been
shown that conventional actins
have one high-affinity binding site
for Mg2 (53), where it is com-
plexed with ATP, and five to nine
low-affinity binding sites that also
interactwithMg2during polymer-
ization and are distributed through-
out the molecule (54). It has further
been shown that addition of Mg2
to the solution of G-actin causes
conformational changes in the pro-
tein because of the interaction of
Mg2 with low affinity sites, rather
than the high affinity site, which
leads to the polymerization of G-ac-
tin into F-actin (55). As molecular
modeling studies with LdACT have
revealed a considerable change in
charge distribution on its solvent-
exposed surface, as compared with
RbACT (Fig. 10A), it is inferred that
modification in the surface charge
distribution might not support the
low affinity interactions of Mg2
with LdACT and thereby may not
allow a sufficient conformational
change in the LdACT structure,
which is favorable for polymeriza-
tion. However, binding of ATP and
Mg2 with LdACT appears to be of sufficient strength to
induce a conformational change that is required for polymeri-
zation. Although comparison of the crystal structures of G-ac-
tin with ATP and ADP showed no major conformation
changes, different profiles of subtilisin digestion of ADP-G-ac-
tin and ATP-G-actin have been explained as a possibility of the
closed state conformation of G-actin in the crystal packing,
which allows sufficient conformational changes during binding
of the protein to the nucleotide in solution (56). Similar to
LdACT, the bacterial homolog of actin, ParM, also essentially
requires the ATP/ATP analog for its polymerization under in
vitro conditions (57).
Another major difference between LdACT and RbACT was
the high sensitivity of LdACT to pH during its polymerization.
Whereas, RbACT polymerized in a wide range of pH from 6.0
to 9.0 and itsmaximumpolymerization occurred at pH 6.0 (58),
LdACTpolymerized only in a narrow range of pH7.0–8.5. This
pH sensitivity of LdACT identifies as a highly diverged form of
eukaryotic actin because most of the actins reported to date
readily polymerized in a wide range of pH. The observed pH-
dependent polymerization of LdACT could partially be attrib-
uted to the change in overall surface charge distribution in
LdACT as compared with conventional actins. Furthermore,
protonation of the charged amino acid residues responsible for
FIGURE 8. Phylogenetic relationship of LdACT with actins from other eukaryotes.
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interaction of ATP in the ATP binding cleft at low pH may
weaken the interactions between ATP and actin, which in turn
may not promote actin polymerization.
The intracellular pH in both Leishmania promastigotes and
amastigotes is maintained at around 7.0 to 7.5 by the highly
efficient proton pumps present in their plasmamembrane (59),
despite the presence of Leishmania amastigotes within the
phagolysosomal compartment of the host macrophages where
they encounter very low pH (5.0). Therefore, pH sensitivity of
actin polymerization should not pose any problem within the
parasites. This is well supported by the presence of filament-like
actin structures in wild type Leishmania promastigotes and actin
cables in actinoverexpressing transgenic promastigotes.As amat-
ter of fact, pH sensitivity of actin is perhaps to the advantage of the
parasite, because it may be exploited to efficiently regulate the
actin dynamics by fine regulation of the intracellular pH.
The Cc of LdACT was about 3–4-fold lower than of conven-
tional actins and the resulting filaments largely existed in the
form of bundles, suggesting that monomer-monomer interac-
tions within and between the filaments in LdACT may be dif-
ferent than in the RbACT. It has earlier been proposed that the
hydrophobic loop (amino acid residues 266–274) in the con-
ventional actinsbetweensubdomains3and4extendedaway from
the monomers and inserted into the hydrophobic pocket formed
by the interface of two monomers in the opposing strands of the
actin double helix (60). Interestingly, this loop is absent in the bac-
terial homologs of actin, MreB and ParM, resulting in diverged
structures of their filaments (61).
The loop is highly diverged in the
case of LdACT (amino acid residues
266–281), which may perhaps be
responsible for its tendency to poly-
merize at relatively low concentra-
tions and also to form bundles due
to altered monomer-monomer in-
teractions between the two strands
of LdACT filaments. Alternatively,
differences in surface charge distri-
bution between LdACT and
RbACT may be responsible for the
bundling property of LdACT fila-
ments. Actin bundling has recently
been shown to play an important
role in endocytosis (62). Interest-
ingly, depletion of actin in the
bloodstream form of T. brucei
focused its role during endocytosis,
which is an indispensable process
for the survival of the parasites (6). It
is therefore likely that the bundling
property of actin may have been
required by these parasites during
endocytosis. Furthermore, Cc of
LdACT in the presence of 5 M
cytochalasin D, which decreases the
polymerization at the barbed ends
but still allows assembly at the
pointed ends, is increased to 0.08
M, suggesting that the mechanism underlying the assembly of
LdACTmonomers into bundlesmay be similar to that reported
earlier for conventional actins (47).
ATP hydrolysis during the polymerization of actin and sub-
sequent release of Pi is themajor factor in regulation of filament
stability (50). This property is conserved from prokaryotic
homologs of actin to all eukaryotic actins (45, 49). Inmost of the
eukaryotic actins release of Pi lags the polymerization, whereas
with the yeast actin it has been shown to be virtually instanta-
neous (63). During polymerization of LdACT, ATP hydrolysis
was found to be higher. In the absence of awell defined catalytic
mechanism of ATP hydrolysis during actin polymerization, it
has been postulated that ATP hydrolysis involves a relatively
closed state conformation of the actin superfamily members
bringing the terminal phosphate of ATP in contact with the
catalytic residues that are believed to be present in the first
major domain (64). Energetically minimized computational
modeling, together with MD simulation analysis revealed that
subdomains 2 and 4 in LdACT are relatively closer than inmus-
cle actin, which results in the reduced cleft volume and also
generates additional direct interactions between Lys19 of
LdACTwith- and -phosphates of ATP.Moreover, similar to
muscle actin, Lys19 and Lys214 showed hydrogen bonding with
the sugarmoiety of ATP, suggesting strong interactions of ATP
with residues of the ATP binding cleft in LdACT and thus
explaining the stronger ATPase activity of LdACT during
polymerization. Alternatively, it may be due to the faster
FIGURE 9. Computational modeling. A, average model of LdACT after molecular dynamic simulations show-
ing colored stretches of diverged amino acid residues (1–9 in subdomain 1, 40–53 in subdomain 2, 266–281
and 307–315 in subdomain 3, 194–200 and 229–240 in subdomain 4), brown ball and stick residues in the
DNase-I binding loop are thediverged replacements in LdACT that are known tomake strong interactionswith
DNase-I in the actinDNase-I complex crystal structure, whereas green ball and stick residues are conserved
amino acid residues that are known to make weak interactions with DNase-I. B, graph showing root mean
square fluctuations (measured in Å) as a function of amino acid residues observed throughout the trajectory of
MD simulation analysis, red, without ATP; and blue, with ATP. C andD are the opposite faces of LdACT average
model showing distribution of diverged amino acid residues throughout the surface of the molecule.
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polymerization of rLdACT that like yeast actin could be due to
the fragmentation of actin filaments, early during the polymer-
ization, with the creation of more seeds (65). Moreover, Pi
release during polymerization of LdACTwas found to be faster
than RbACT, which may be due to excessive treadmilling dur-
ing the polymerization of LdACT suggesting high dynamics of
LdACT filaments during the course of polymerization. Fur-
thermore, the rate of ATP hydrolysis during rLdACT polymer-
ization plateaus after 2 M concentration, which could be
attributed to the bundling property of rLdACT filaments
beyond that concentration, leaving a large proportion of ATP-
actin in the filaments. This further gains strength from the elec-
tron microscopic images of rLdACT filaments, which at 2 M
concentration, unlike RbACT,mainly existed as bundles. Inter-
estingly, GTP binding with LdACT did not facilitate polymeri-
zation despite the presence of Phe307, which in the case of yeast
actin has been shown to facilitate actin polymerization (66).
This may be attributed to the orientation of the - and -phos-
phate groups with respect to the heterocyclic ring that in the
case of GTP may not be appropriate to facilitate additional
interactions between these groups and Lys19 of LdACT.
A striking feature of rLdACT was
its inability to inhibit DNase-I activ-
ity, which was consistent with an
earlier report where no binding of
DNase-I with trypanosomatid actin
was observed in whole cell lysates
(18). The lack of DNase-I inhibition
activity is primarily due to the pres-
ence of highly divergent amino acid
residues in the DNase-I binding
region, because Gly42, Val43, and
Met44 of actin in the DNase-Iactin
complex have been shown to form
the major site for DNase-I interac-
tions with actin (41), and these
amino acid residues in LdACT have
been replaced by Met, Gln, and Ala,
respectively. Another feature of
LdACT that distinguishes it from
conventional actins was its inability
to bind phalloidin, which is a bicy-
clic peptide that binds with consec-
utive actin monomers in the fila-
mentous actin (60, 67). Although
amino acid residues responsible for
interactions with phalloidin are
conserved in LdACT, but altered
monomer-monomer interactions
within and/or between the LdACT
filaments in bundles, compared
with conventional actins, might
have resulted in masking of the
phalloidin binding sites. Similarly,
failure of LdACT to bind with
Latrunculin B, which is known to
disrupt actin polymerization,
despite having all the amino acid
residues that form the binding site (68) conserved in its struc-
ture, may be attributed to the overall structural differences
between LdACT and conventional actins.
Based on these results, we conclude that LdACT is a novel
form of actin that displays unique biochemical properties that
have not been reported for any other actin to date. Finally, we
suggest that LdACT could serve as an attractive target for
designing novel antileishmanial drugs.
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